The global plastic catheter market size was estimated at USD 4.61 billion in 2024 and is projected to grow at a CAGR of 5.7% from 2025 to 2030. The market growth is attributed to the growing number of surgeries worldwide, which is increasing the demand for plastic catheters, especially in procedures requiring precise fluid management.
Additionally, improvements in catheter design for better patient comfort are encouraging more hospitals to upgrade their devices. The market represents a critical segment of the global medical devices industry, defined by its adaptability, biocompatibility, and cost-efficiency.
The plastic catheter market is witnessing a transition towards next-generation materials such as bioresorbable polymers and antimicrobial-coated plastics, driven by the demand for safer and more patient-compliant devices. This trend is reinforced by advancements in extrusion technologies, enabling the production of highly flexible, kink-resistant, and miniaturized catheters suitable for complex interventional procedures. Increasing reliance on minimally invasive surgeries has amplified the need for catheters with higher biocompatibility and functional versatility, shaping product innovation and design across major manufacturers.
A key growth driver for the plastic catheter market is the escalating global prevalence of chronic diseases such as cardiovascular disorders, end-stage renal disease, and urological conditions. These health burdens are intensifying the clinical demand for catheterization across both acute care and long-term treatment settings. Moreover, the rising adoption of interventional therapies in aging populations is fueling consistent procedural volumes, thereby expanding the utilization of plastic catheters across hospitals and outpatient surgical centers.
Emerging economies present a lucrative opportunity for plastic catheter manufacturers, particularly in regions with improving healthcare infrastructure and rising access to surgical care. Countries in Southeast Asia, Latin America, and Sub-Saharan Africa are increasingly prioritizing investments in hospital equipment and infection prevention, creating a receptive market for cost-effective, high-performance catheter solutions. Partnerships with local distributors and healthcare providers can unlock long-term market penetration strategies in these under-tapped geographies.
The growing scrutiny over environmental sustainability and plastic waste generated by single-use medical devices is a major restrain of the market. Regulatory pressure from environmental agencies and hospital procurement bodies is pushing for biodegradable or recyclable alternatives, posing cost and compliance challenges for manufacturers relying on conventional polymers.
The market growth stage of the plastic catheter market is medium, and the pace is accelerating. The market exhibits a significant level of market concentration, with key players dominating the industry landscape. Major companies such as Becton, Dickinson, and Company, Coloplast, Hollister Incorporated, Teleflex, Medtronic plc, Boston Scientific, Cook Medical, ConvaTec, B. Braun, and others play a significant role in shaping the market dynamics. These leading players often drive innovation within the market, introducing new products, technologies, and materials to meet evolving industry demands.
Advancements in material science and manufacturing techniques are driving a new wave of innovation in plastic catheters, with bioresorbable polymers and antimicrobial surface treatments entering late-stage development. Additive manufacturing is enabling bespoke catheter geometries that optimize flow dynamics and reduce tissue trauma during insertion. Integration of micro-sensors for real-time pressure and flow monitoring is also gaining traction, positioning catheters as proactive diagnostic tools rather than passive conduits. Collectively, these innovations are expanding the clinical utility of plastic catheters across diverse procedural settings.
Stringent regulatory frameworks, such as the EU Medical Device Regulation (MDR) and updated FDA guidance on single-use devices, are reshaping product lifecycles and market entry timelines for catheter manufacturers. Compliance with ISO 13485 quality management standards and heightened scrutiny of plasticizer leachables necessitates substantial investment in testing and process validation. Meanwhile, emerging environmental mandates on medical plastic waste are compelling R&D teams to explore recyclable and compostable alternatives. As a result, regulatory alignment has become a critical strategic focal point for sustaining competitive advantage.
Foley catheters dominated the plastic catheter market across the type segmentation in terms of revenue, accounting for a market share of 56.05% in 2024. The sustained rise in postoperative and critical care procedures is driving robust growth in the Foley catheter segment, as clinicians prioritize continuous bladder drainage for patients undergoing extended surgeries or immobilization. Enhanced product differentiation, such as dual-lumen designs and radiopaque tips, is enabling hospitals to streamline catheter management and reduce complication rates.
The intermittent catheters segment is anticipated to grow at a significant CAGR of 6.45% through the forecast period. Home healthcare expansion and the shift toward outpatient urology practices are propelling demand for intermittent catheters, particularly among neurogenic and mobility-impaired patient populations. Innovations in no-touch coating technologies and compact packaging are improving ease of use and reducing infection risk, which appeals to both carers and self-catheterizing individuals. As insurers increasingly cover at-home catheterization supplies, intermittent catheters are gaining traction as a cost-effective alternative to indwelling devices.
PVC-based dominated the plastic catheter market across the material segmentation in terms of revenue, accounting for a market share of 58.63% in 2024. PVC-based catheters continue to capture market share owing to their low production costs and established manufacturing ecosystems, which support high-volume output and competitive pricing. Recent advances in plasticizer-free formulations are addressing historical biocompatibility concerns without significantly increasing material costs. This combination of economic efficiency and improving safety profiles makes PVC-based catheters especially attractive for large hospital groups focused on value-based procurement.
The silicone-based segment is projected to witness a rapid CAGR of 6.4% through the forecast period. Silicone-based catheters are witnessing accelerated adoption as regulatory bodies and clinical guidelines emphasize long-term biocompatibility and reduced encrustation for indwelling applications. Their inherent flexibility and inert surface chemistry minimize patient discomfort and lower the incidence of catheter-associated urinary tract infections (CAUTIs), driving preference in high-risk cohorts. Premium pricing strategies are further supported by bundled quality assurance programs, positioning silicone catheters as a strategic choice for differentiated care pathways.
North America plastic catheter market dominated the global market and accounted for the largest revenue share of 37.64% in 2024. In North America, the transition toward grid modernization and decentralized energy storage is a primary driver for plastic catheter. With increasing investment in utility-scale battery storage and smart grid infrastructure, especially across Canada and select U.S. states, film capacitors are vital for managing power quality and stabilizing frequency response. This trend is further reinforced by incentives under climate-driven legislation like the U.S. Inflation Reduction Act, which accelerates demand for durable and high-efficiency capacitor components.
The U.S. market is being specifically propelled by the rapid scaling of domestic electric vehicle production and associated charging infrastructure. Major automakers and EV startups are localizing battery and power electronics manufacturing, requiring advanced film capacitors in DC link and inverter systems. Moreover, the Department of Energy’s emphasis on reshoring critical components in the EV supply chain is creating strategic opportunities for capacitor film producers to establish local manufacturing footprints.
Europe’s plastic catheter market is being driven by stringent regulatory pressure to decarbonize its transport and energy sectors. The European Green Deal and the Fit for 55 initiatives are pushing automakers and renewable energy developers to adopt high-efficiency electrical systems that rely heavily on film capacitors for their reliability and low-loss characteristics.
Asia Pacific continues to lead global growth in plastic catheter due to the rapid expansion of its electronics manufacturing base and accelerating adoption of industrial automation. Markets like South Korea, Japan, and India are heavily investing in smart manufacturing, robotics, and 5G infrastructure, which rely on compact, stable film capacitors.
China plastic catheter market is being aggressively driven by state-backed initiatives to dominate electric mobility and renewable energy technologies. The country’s leadership in EV manufacturing directly boosts demand for high-performance film capacitors used in traction inverters and onboard electronics. Simultaneously, China's investments in solar and wind energy, combined with a maturing ultra-high-voltage (UHV) transmission network, are creating consistent demand for large-format plastic catheter with high dielectric endurance.
The Plastic Catheter Market is highly competitive, with several key players dominating the landscape. Major companies include Becton, Dickinson, and Company, Coloplast, Hollister Incorporated, Teleflex, Medtronic plc, Boston Scientific, Cook Medical, ConvaTec, and B. Braun. The plastic catheter market is characterized by a competitive landscape with several key players driving innovation and market growth. Major companies in this sector are investing heavily in research and development to enhance the performance, cost-effectiveness, and sustainability of their types.
The following are the leading companies in the plastic catheter market. These companies collectively hold the largest market share and dictate industry trends.
In January 2025, medical device company BD committed over USD 10 million to expand its US manufacturing capacity for syringes, needles, and IV catheters.
In May 2024, Coloplast expanded its Luja catheter portfolio by launching a next-generation intermittent catheter designed specifically for women, starting in Denmark and Italy. Building on the success of the male Luja catheter, this new female version features Micro-hole Zone Technology with over 50 micro-holes, enabling complete bladder emptying in one free flow, which helps reduce the risk of urinary tract infections.
Report Attribute |
Details |
Market size value in 2025 |
USD 4.83 billion |
Revenue forecast in 2030 |
USD 6.38 billion |
Growth rate |
CAGR of 5.7% from 2025 to 2030 |
Actual data |
2018 - 2024 |
Forecast period |
2025 - 2030 |
Quantitative units |
Revenue in USD million/billion, Volume in Kilotons, and CAGR from 2025 to 2030 |
Report coverage |
Volume & revenue forecast, competitive landscape, growth factors, and trends |
Segments covered |
Type, material, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; China; India; Japan; South Korea; Australia Brazil; Argentina; Saudi Arabia; South Africa; UAE |
Key companies profiled |
Becton, Dickinson, and Company; Coloplast; Hollister Incorporated; Teleflex; Medtronic plc; Boston Scientific; Cook Medical; ConvaTec; B. Braun |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global plastic catheter market report based on type, material, and region:
Type Outlook (Revenue, USD Million; Volume, Kilotons, 2018 - 2030)
Foley Catheters
Intermittent Catheters
External Catheters
Suprapubic Catheters
Other Types
Material Outlook (Revenue, USD Million; Volume, Kilotons, 2018 - 2030)
PVC-based
Silicone-based
Polyurethane (PU)
Latex
Others
Regional Outlook (Revenue, USD Million; Volume, Kilotons, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Asia Pacific
China
India
Japan
South Korea
Australia
Latin America
Brazil
Argentina
Middle East & Africa
Saudi Arabia
South Africa
UAE
b. The global plastic catheter market size was estimated at USD 4.61 billion in 2024 and is expected to reach USD 4.83 billion in 2025.
b. The global plastic catheter market is expected to grow at a compound annual growth rate of 5.75% from 2025 to 2030 to reach USD 6.38 billion by 2030.
b. Foley catheters dominated the plastic catheter market across the type segmentation in terms of revenue, accounting for a market share of 56.05% in 2024. The sustained rise in postoperative and critical care procedures is driving robust growth in the segment, as clinicians prioritize continuous bladder drainage for patients undergoing extended surgeries or immobilization.
b. Some key players operating in the plastic catheter market include Becton, Dickinson, and Company, Coloplast, Hollister Incorporated, Teleflex, Medtronic plc, Boston Scientific, Cook Medical, ConvaTec, and B. Braun.
b. The growing number of surgeries worldwide is increasing the demand for plastic catheters, especially in procedures requiring precise fluid management. Additionally, improvements in catheter design for better patient comfort are encouraging more hospitals to upgrade their devices.
NEED A CUSTOM REPORT?
We offer custom report options, including stand-alone sections and country-level data. Special pricing is available for start-ups and universities.
Request CustomizationWe are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."